Maravai LifeSciences Holdings, Inc. MRVI Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s finance lease liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported finance lease liabilities of $29.87M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s finance lease liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s finance lease liabilities decreased by 3.3% year-over-year, from $30.88M to $29.87M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s finance lease liabilities?
- Over 4 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s finance lease liabilities has grown at a -14.4% compound annual growth rate (CAGR), from $56.17M to $30.14M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.